Search

everythinglearnresearchcommunity

for

Search:↓

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Triamcinolone hexacetonide is effective but has side effects, while PRP and minoxidil are safer alternatives for treating alopecia areata.

Finasteride may affect female fertility by altering gene activity.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Activating TRPV4 in skin cells helps regrow hair in mice, possibly offering a treatment for hair loss.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

Abrocitinib may effectively treat stubborn alopecia universalis.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Finasteride 1mg linked to diverse symptoms; other treatments improve erectile function in rats.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

Disrupting the Tsc2 gene in certain cells leads to thicker skin, larger hair, and changes in hair growth signaling, which can be partly reversed with specific treatment.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Sox13 is a marker for early hair follicle development but not essential for skin and hair growth.

Trichoriboside treatment helps maintain scalp hair by increasing cAMP levels in hair follicles of men with hair loss.